Member Info for dragon101

I think this is a different situation, it looks like the market actually likes this OO.
I will also ask for extra shares but I am not very optimistic.

Based on pervious experience I think we have very little chance of getting any extra shares.

http://www.trackhedgefunds.com/redmile-group

I am not sure if anyone read this interesting article on the BBC Future web page on the importance of T cells.
https://www.bbc.com/future/article/20200716-the-people-with-hidden-protection-from-covid-19?fbclid=IwAR0cpYNU0wzgiC-BPFkJIRV9a-0e4AdUFeRzHbv9YAC7H_8uwJ2EhBulOio

Very interesting, thanks for sharing.
They also discuss the Oxford trial.

Jeremy Green is the founder and portfolio manager of Redmile Group, LLC, a San Francisco-based investment firm that focuses on the health care sector. Prior to founding Redmile, Jeremy was cofounder and director of research at Steeple Capital and an analyst at Andor Capital. Prior to moving to the US in 2004, Jeremy was a managing director at Citigroup and head of the European Healthcare Research Team covering medical technology, biotech, and health care services. Jeremy has a master’s degree (biological sciences) from Oxford University, where he was president of the Oxford Union Society. Having previously been a non-executive director of friends of The Prince’s Trust, he currently serves as a chairman of Prince’s Trust America. Jeremy currently serves on the board of directors of Alder Biopharmaceuticals (ALDR). Jeremy is a Fellow of the fourth class of the Health Innovators Fellowship and a member of the Aspen Global Leadership Network.

Redmile Group is a hedge fund company based in San Francisco, CA. They operate 10 private funds and have approximately $2.34 billion in total assets under management (AUM)

Has anyone else found out any more information about this group?

Thanks.

Hi everyone,

Any ideas on value of any potential AvidiMab deals.

Nice one!

To be honest, I thought it was quite a long segment.(nearly 3 minutes)
https://news.sky.com/story/watch-sky-news-live-10315632
Rewind to around 6:55pm

Great to see Scancell, applying some pressure to the government. Very informative segment on Sky for the layperson.

Hopefully it's from 7am tomorrow morning after a blockbuster RNS.

Sorry about the duplication, just catching up on previous posts.

Scientists at rival universities have complained that their applications for state funding have gone unanswered. Nottingham University has teamed up with AIM-listed biotech start-up Scancell to repurpose its cancer vaccine tech for the coronavirus.

Lindy Durrant, chief scientific officer of Scancell and a professor of cancer immunology at Nottingham, has developed a vaccine that prompts a T-cell response and virus-neutralising antibodies against Sars-Cov-2, the virus that causes Covid-19. Scancell believes the combination could lead to longer-lasting immunity.

Unlike the Imperial and Oxford projects, Scancell is yet to receive any funding. Requests to UK Research and Innovation, responsible for handing out grants, have so far gone unanswered. Instead, senior executives have taken a 20% pay cut in order to fund the early-stage work; they will need several million pounds in funding to begin human trials.

“If we get modest funding we can start at the beginning of next year,” said Durrant. “If we get a bit more, we could start in the next three months.” Durrant remains hopeful that ministers will eventually respond to Scancell’s pleas.

While scientists are working to push experimental vaccines through trials, behind the scenes, Britain’s biotech industry is gearing up for an extraordinary manufacturing effort — agreeing to waive profits during the pandemic in a bid to ensure any vaccine is affordable to everyone.

Just offer to give the tech to the US government.
They will give MODERNA up to $483 million to accelerate development of their mRNA Vaccine.

Not sure if anyone has noticed the announcement from BJ regarding the 93 million investment in a new vaccine centre at Oxford Science Park .
https://www.dailymail.co.uk/news/article-8326925/Government-inject-93-million-new-vaccine-lab-Oxfordshire-cure-Covid-19.html

Fascinating insights in to how Covid 19 spreads in the community:
https://www.erinbromage.com/post/the-risks-know-them-avoid-them

https://www.washingtonpost.com/business/2020/05/11/coronavirus-vaccine-global-supply/

No paywall.

https://www.google.com/amp/s/amp.ft.com/content/3bb6f5d4-8e14-11ea-af59-5283fc4c0cb0